Literature DB >> 3601280

The effect of chorioamnionitis on the developmental outcome of preterm infants at one year.

W J Morales.   

Abstract

This report investigates the effect of chorioamnionitis on infant mental and psychomotor development at one year through the prospective study of 698 preterm pregnancies complicated by premature rupture of membranes and managed expectantly without antenatal corticosteroids or tocolytic agents. Ninety-two mothers (13%) developed chorioamnionitis, resulting in a statistically significant increase in neonatal mortality (25 versus 6%), respiratory distress syndrome (RDS) (62 versus 35%), intraventricular hemorrhage (56 versus 22%), and sepsis (28 versus 11%). A multidisciplinary team examined 43 surviving infants at corrected one year of life and measured their mental and psychomotor development by the Bayley scales. No statistically significant difference in outcomes was observed when their development was compared with that of a control group matched for birth weight, gestational age, severity of intraventricular hemorrhage, and severity of RDS.

Entities:  

Mesh:

Year:  1987        PMID: 3601280

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  Placental pathology and intraventricular hemorrhage in preterm and small for gestational age infants.

Authors:  Mohamed Mohamed; Anna A Penn; Melissa A Oh; Stephanie Barak
Journal:  J Perinatol       Date:  2021-03-01       Impact factor: 2.521

2.  Neonatal brain damage following prolonged latency after preterm premature rupture of membranes.

Authors:  Su Hyun Park; Hai Joong Kim; Jae Hyug Yang; June Seek Choi; Ji Eun Lim; Min Jeong Oh; Jung Yeol Na
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

3.  Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis.

Authors:  Celeste Beck; Kelly Gallagher; Leigh A Taylor; Jeffery A Goldstein; Leena B Mithal; Alison D Gernand
Journal:  Obstet Gynecol       Date:  2021-06-01       Impact factor: 7.623

4.  Modern management of clinical chorioamnionitis.

Authors:  T Westover; R A Knuppel
Journal:  Infect Dis Obstet Gynecol       Date:  1995

5.  Chorioamnionitis as a risk factor for retinopathy of prematurity: An updated systematic review and meta-analysis.

Authors:  Eduardo Villamor-Martinez; Giacomo Cavallaro; Genny Raffaeli; Owais M M Mohammed Rahim; Silvia Gulden; Amro M T Ghazi; Fabio Mosca; Pieter Degraeuwe; Eduardo Villamor
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

6.  Maternal chorioamnionitis and neurodevelopmental outcomes in preterm and very preterm neonates: A meta-analysis.

Authors:  Dongqiong Xiao; Tingting Zhu; Yi Qu; Xiaoyun Gou; Qun Huang; Xihong Li; Dezhi Mu
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

7.  Antenatal infection and intraventricular hemorrhage in preterm infants: A meta-analysis.

Authors:  Jinglan Huang; Junjie Meng; Imti Choonara; Tao Xiong; Yibin Wang; Huiqing Wang; Yi Qu; Dezhi Mu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 8.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

9.  Impact of Co-Existing Placental Pathologies in Pregnancies Complicated by Placental Abruption and Acute Neonatal Outcomes.

Authors:  Dorsa Mavedatnia; Jason Tran; Irina Oltean; Vid Bijelić; Felipe Moretti; Sarah Lawrence; Dina El Demellawy
Journal:  J Clin Med       Date:  2021-12-03       Impact factor: 4.241

10.  Chorioamnionitis Is a Risk Factor for Intraventricular Hemorrhage in Preterm Infants: A Systematic Review and Meta-Analysis.

Authors:  Eduardo Villamor-Martinez; Monica Fumagalli; Owais Mohammed Rahim; Sofia Passera; Giacomo Cavallaro; Pieter Degraeuwe; Fabio Mosca; Eduardo Villamor
Journal:  Front Physiol       Date:  2018-09-11       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.